Recently, a study identified a hypomethylated ER‐positive breast cancer subtype presenting the best survival probability compared with the hypermethylated ER+ and hypomethylated ER‐negative subtypes, where certain upregulated genes like SFRP1 and WIF have great potential to suppress the progression of ER+ breast cancer. This evidence concerns the gene ESR1 and breast cancer.